Random Posts
- Bad News - This is What You Might Have to Face With Diabetes
- What is a Healthy Eating Plan to Help With Weight Loss and Your Blood Sugar Levels?
- Why Do You Get Wildly Fluctuating Blood Sugar Levels Although You Eat the Same Way Every Day?
- Turmeric For Diabetes - Diagnosis, Control and Prevention
- Is Type II Diabetes Reversible?
- Nursing Care Plans For Diabetes
Prescription Diabetes Drugs
Posted by admin in Prescription Diabetes Drugs on October 31st, 2010
Retrospective analysis of a US health-care plan claims database reveals patients with diabetes hospitalized for a cardiovascular (CV) event incur higher costs and resource use than their counterparts without diabetes.
Excess medical expenses and reduced productivity due to diabetes represent a significant economic burden for the US health-care system.
As CV complications are generally the most costly component of medical care in patients with diabetes, Robert Straka (University of Minnesota College of Pharmacy, Minneapolis, USA) and colleagues compared real-world costs associated with initial and subsequent CV events in patients with and without the disease.
The authors identified 29,863 patients hospitalized for a CV event between January 2001 and June 2005 from a large US managed-care population. Of these, 5501 (18.4%) patients had a history of diabetes.
Direct medical costs and resource use for all CV events combined were determined for patients with or without diabetes. The researchers also calculated costs and resource use by type of CV event, eg, coronary artery bypass graft, myocardial infarction, or ischemic stroke.
Mean direct medical costs per patient for the initial CV hospitalization and for the first recurrent CV hospitalization were similar for patients with and without diabetes.
However, during the follow-up period, patients with diabetes experienced a higher incidence of subsequent CV events than the non-diabetic cohort for each event type.
As a result, medical costs for CV care during the follow-up period were consistently higher in the diabetic cohort with mean total direct medical costs per patient of US$8805 (€5964) versus $6982 (€4729) in year 1, $13,860 (€9390) versus $10,056 (€6813) in year 2, and $16,149 (€10,942) versus $12,163 (€8241) in year 3.
The cost difference between diabetic and non-diabetic patients remained significant after adjusting for age, gender, and other potential confounders.
Patients with diabetes also experienced longer periods of inpatient cardiovascular hospitalization than those without the disease with a mean of 3.3 versus 1.8 days.
“Taking into account expenditures for the initial cardiovascular hospitalization plus all CV events during the follow-up period, the incremental per-patient cost attached to CV events in patients with diabetes was $10,131 (€6865) over 3 years,” write the authors.
“The real-world cost estimates described here will aid the development of future economic models that assess the impact of health-care initiatives aimed at this growing diabetic population,” they conclude in the journal Cardiovascular Diabetology.
MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2009
- Living With Charcot Foot & Diabetic Neuropathy Requires Support
- Does Acai Berry Help Diabetes? Find Out Here
- Step Out to Help Fight Diabetes
- What Role Does Whole-Grain Food Have in Regards to Type 2 Diabetics?
- Getting Diabetic Supplies on the Internet
- Target Blood Glucose Level For a Diabetic Type 2 and Why This is Important
- Diabetes Incidence Estimates
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.